Biomarker approaches for optimisation of antiangiogenic therapy

Date 07 May 2017
Event ELCC 2017
Session The role of antiangiogenic agents in NSCLC: Are we making progress?
Topics Lung and other Thoracic Tumours
Translational Research
Presenter Martin Reck
Authors M. Reck
  • Department Of Thoracic Oncology, LungenClinic Grosshansdorf, Grosshansdorf/DE